AR

Arcutis Biotherapeutics IncNASDAQ ARQT Stock Report

Last reporting period 30 Jun, 2024

Updated 06 Nov, 2024

Last price

Market cap $B

1.132

Small

Exchange

XNAS - Nasdaq

View Full Company Analysis

Arcutis Current ratio

8.1

Last period Current ratio


What is Current ratio ?

Current ratio is the company's ability to repay all its short-term liabilities with available liquid assets. The value of 1.5 is the benchmark for Eyestock Rating calculation.

What is Current ratio ?

Current ratio is the company's ability to repay all its short-term liabilities with available liquid assets. The value of 1.5 is the benchmark for Eyestock Rating calculation.

What is Current ratio of Arcutis ?

Arcutis`s Current ratio for the last twelve months ended 2024-06-30 is 8.1

View Full Company Analysis